CFRX
Price:
$0.2318
Market Cap:
$1.72M
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company also develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staphylococcus aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis; and CF-370, an investigational anti-bacterial therapeutic candidate, which is in Phase 1 clinical tr...[Read more]
Industry
Biotechnology
IPO Date
2014-09-12
Stock Exchange
NASDAQ
Ticker
CFRX
According to ContraFect Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -80.36% compared to the average of -0.10 of the last 4 quarters.
The mean historical PE Ratio of ContraFect Corporation over the last ten years is -1.07. The current -0.02 PE Ratio has changed 86.96% with respect to the historical average. Over the past ten years (40 quarters), CFRX's PE Ratio was at its highest in in the December 2016 quarter at 30.66. The PE Ratio was at its lowest in in the September 2017 quarter at -11.44.
Average
-1.07
Median
-2.72
Minimum
-4.41
Maximum
14.12
Discovering the peaks and valleys of ContraFect Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 323.48%
Maximum Annual PE Ratio = 14.12
Minimum Annual Increase = -443.81%
Minimum Annual PE Ratio = -4.41
Year | PE Ratio | Change |
---|---|---|
2022 | -0.06 | -100.43% |
2021 | 14.12 | -443.81% |
2020 | -4.11 | 0.81% |
2019 | -4.07 | 31.93% |
2018 | -3.09 | -14.66% |
2017 | -3.62 | 75.94% |
2016 | -2.06 | -53.38% |
2015 | -4.41 | 323.48% |
2014 | -1.04 | -55.87% |
2013 | -2.36 | 56.94% |
The current PE Ratio of ContraFect Corporation (CFRX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
3.32
5-year avg
0.56
10-year avg
-1.07
ContraFect Corporation’s PE Ratio is less than Palisade Bio, Inc. (0), greater than Allarity Therapeutics, Inc. (-0.31), greater than CNS Pharmaceuticals, Inc. (-0.19), less than Windtree Therapeutics, Inc. (-0.00), greater than Quoin Pharmaceuticals, Ltd. (-0.14), greater than Revelation Biosciences, Inc. (-0.47), greater than Virax Biolabs Group Limited (-0.09), greater than Unicycive Therapeutics, Inc. (-1.34), greater than NeuroBo Pharmaceuticals, Inc. (-0.46), greater than Hillstream BioPharma, Inc. (-0.73), less than First Wave BioPharma, Inc. (-0.00), greater than Dermata Therapeutics, Inc. (-0.85), greater than Panbela Therapeutics, Inc. (-0.11), greater than null (-0.06),
Company | PE Ratio | Market cap |
---|---|---|
0 | $4.25M | |
-0.31 | $7.01M | |
-0.19 | $4.60M | |
-0.00 | $1.66M | |
-0.14 | $3.06M | |
-0.47 | $1.43M | |
-0.09 | $15.24M | |
-1.34 | $33.41M | |
-0.46 | $29.70M | |
-0.73 | $4.17M | |
-0.00 | $5.99M | |
-0.85 | $2.08M | |
-0.11 | $1.75M | |
-0.06 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ContraFect Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ContraFect Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is ContraFect Corporation's PE Ratio?
How is the PE Ratio calculated for ContraFect Corporation (CFRX)?
What is the highest PE Ratio for ContraFect Corporation (CFRX)?
What is the 3-year average PE Ratio for ContraFect Corporation (CFRX)?
What is the 5-year average PE Ratio for ContraFect Corporation (CFRX)?
How does the current PE Ratio for ContraFect Corporation (CFRX) compare to its historical average?